Key result
Obese children had higher cIMT and lower FMD responses than controls, while circulating endoglin and obestatin levels were not predictive markers.
Why the study?
Are serum endoglin and obestatin levels predictive markers for subclinical atherosclerosis in obese children?
Case-Control (n=95)
Are serum endoglin and obestatin levels predictive markers for subclinical atherosclerosis in obese children?
While obese children show early signs of subclinical atherosclerosis via increased cIMT and decreased FMD, circulating endoglin and obestatin levels are not useful predictive markers for this condition.
Answers are grounded in this paper and cite their sources.
Endoglin and obestatin levels should not guide subclinical atherosclerosis assessment in obese children; hypothesis-generating for alternative biomarkers.
BACKGROUND: The aim of this study was to investigate the early signs of atherosclerosis and to evaluate serum endoglin and obestatin levels as predictors of subclinical atherosclerosis in obese children. METHODS: A total of 95 children (60 obese and 35 controls) aged 10-18 years were included in the study. Their endoglin and obestatin levels and biochemical parameters were measured. The carotid intima media thickness (cIMT) and brachial artery flow-mediated dilatation (FMD) responses were evaluated. RESULTS: The cIMT values were higher (p < 0.001) and FMD responses were lower (p = 0.003) in the obese group than in the control group. A logistic regression multivariate analysis revealed that cIMT was independently associated with the body mass index (BMI) Z-score (β = 0.323, p = 0.003) and low density lipoprotein (LDL) (β = 0.29, p = 0.008), while FMD % was independently associated with waist circumference (β = -0.36, p = 0.002). The obese and control groups were similar in endoglin (p = 0.67) and obestatin levels (p = 0.70). The endoglin level was inversely correlated with the cholesterol and LDL levels (r = -0.23, p = 0.032; rho = -0.25, p = 0.019). CONCLUSIONS: The cIMT and brachial artery FMD response in obese children are significantly different compared to healthy controls. Circulating endoglin and obestatin levels are not predictive markers for subclinical atherosclerosis in obese children aged 10-18 years old.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2016) conducted a case-control in Obesity (n=95). Obesity vs. Healthy controls was evaluated on Carotid intima media thickness (cIMT) and brachial artery flow-mediated dilatation (FMD) (p=<0.001). Obese children had higher cIMT and lower FMD responses than controls, while circulating endoglin and obestatin levels were not predictive markers.
Synapse has enriched 10 related papers. Consider them for comparative context: